Skip to main content
Premium Trial:

Request an Annual Quote

David Creed, Eleanor Mitchell, Terry Hurley, Chris Brown, Brigitte Bren, Robert Lauer, Robert Mandell, Jan Tuttleman, Andrew Viterbi, Gayle Wilson, Dirk Thomas, Robert Auchter, Kenneth Freeling

Premium

ITI Scotland last week announced a new organizational structure “to better equip the company to meet its agreed strategic objectives.”
 
David Creed, CEO of ITI Techmedia and COO of ITI Scotland, has been appointed to the role of group chief executive of ITI Scotland.
 
In addition, Eleanor Mitchell, former acting CEO of ITI Life Sciences, has been appointed managing director of ITI Life Sciences; Terry Hurley, director of technology, markets, and programs at ITI Techmedia, will now become its managing director; and Chris Brown, formerly of the BOC Group, has been appointed as interim managing director of ITI Energy. All managing directors will report to Creed, ITI Scotland said.
 
In addition, ITI Scotland said that a group director of IP and commercialization will be appointed to implement group policy for the protection, management, and commercialization of intellectual assets. The group director will oversee these efforts for each of ITI’s three divisions: Energy, Life Sciences, and Techmedia.
 
ITI Scotland is a commercial organization focused on driving sustainable economic growth in Scotland through ownership of commercially targeted R&D programs.
 

 
The Burnham Institute for Medical Research last week announced the election of six new members to its board of trustees:
 
  • Brigitte Bren, president and CEO of International Strategic Planning
  • Robert Lauer, principal at Lauer, Georgatos & Associates
  • Robert Mandell, chairman, Meritage Homes, of Central Florida
  • Jan Tuttleman, consultant, Progenetor
  • Andrew Viterbi, president, Viterbi Group
  • Gayle Wilson, California’s First Lady, 1991-1996

 
Dewey Ballantine last week announced that Dirk Thomas, Robert Auchter, and Kenneth Freeling will join the firm’s Washington, DC, office this week as partners in the intellectual property litigation group.
 
The firm also announced that Thomas will serve as co-chair of the firm-wide IP litigation group alongside Aldo Badini.
 
Thomas, Aucheter, and Freeling all join Dewey Ballantine from the Washington, DC, offices of Robins, Kaplan, Miller & Ciresi.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.